B-FABP Activators
B-FABP activators, in this context, are chemicals that can indirectly influence the activity or expression of Brain-Type Fatty Acid Binding Protein. B-FABP's primary function is to bind and transport long-chain fatty acids in the brain, and its activity is closely tied to lipid metabolism and cellular fatty acid levels.
Omega-3 fatty acids like DHA and EPA are natural ligands for fatty acid binding proteins. By increasing the availability of these fatty acids, B-FABP activity could be indirectly modulated. Lithium chloride, known for its effects on neural function, might also influence B-FABP expression in brain tissues.
Curcumin and resveratrol, with their broad effects on cellular signaling and metabolism, might impact lipid metabolism pathways and thereby influence B-FABP function. PPARγ agonists like pioglitazone and rosiglitazone are known to regulate lipid metabolism and could have implications for B-FABP activity.Metformin, commonly used in diabetes management, influences metabolic pathways, including lipid metabolism, which could affect B-FABP. Similarly, lipid-lowering drugs like fenofibrate and simvastatin might modulate B-FABP function by altering lipid profiles. Niacin (Vitamin B3), with its role in managing lipid levels, could also indirectly influence B-FABP activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $92.00 $206.00 $1744.00 $7864.00 $16330.00 | 11 | |
DHA, an omega-3 fatty acid, is a natural ligand for FABPs and may influence B-FABP activity. | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $102.00 $423.00 | ||
EPA, another omega-3 fatty acid, could bind to and modulate B-FABP function. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can modulate signaling pathways and might influence B-FABP expression in neural tissues. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin affects multiple signaling pathways and might influence lipid metabolism and B-FABP activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol can modulate various signaling pathways, potentially affecting B-FABP function. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $42.00 $62.00 $153.00 $255.00 $500.00 $30.00 | 37 | |
Metformin, primarily used for type 2 diabetes, can influence lipid metabolism and may affect B-FABP. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $40.00 | 9 | |
Fenofibrate, a lipid-lowering drug, can modulate lipid metabolism and potentially B-FABP activity. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $30.00 $87.00 $132.00 $434.00 | 13 | |
Simvastatin, a statin used for cholesterol management, might influence lipid metabolism and B-FABP function. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $61.00 $122.00 | 1 | |
Niacin can affect lipid profiles and may indirectly influence B-FABP activity. | ||||||